Therefore, we have also elicited the cancer patient’s survival analysis based on the higher or lower expression of SERTAD1 which may appear baseline for development of fabulous and novel treatment strategies for various types of cancers including breast cancer. This evidence concerns the gene SERTAD1 and breast carcinoma.